These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9446626)

  • 21. Inhibition of angiogenesis in vitro and in vivo: comparison of the relative activities of triflavin, an Arg-Gly-Asp-containing peptide and anti-alpha(v)beta3 integrin monoclonal antibody.
    Sheu JR; Yen MH; Kan YC; Hung WC; Chang PT; Luk HN
    Biochim Biophys Acta; 1997 Oct; 1336(3):445-54. PubMed ID: 9367172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of cyclooxygenase-1 and -2 modulates angiogenic responses to engagement of alphavbeta3.
    Murphy JF; Steele C; Belton O; Fitzgerald DJ
    Br J Haematol; 2003 Apr; 121(1):157-64. PubMed ID: 12670347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyr61, product of a growth factor-inducible immediate early gene, is associated with the extracellular matrix and the cell surface.
    Yang GP; Lau LF
    Cell Growth Differ; 1991 Jul; 2(7):351-7. PubMed ID: 1782153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family.
    Lin CG; Leu SJ; Chen N; Tebeau CM; Lin SX; Yeung CY; Lau LF
    J Biol Chem; 2003 Jun; 278(26):24200-8. PubMed ID: 12695522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrin alphavbeta3 is not significantly implicated in the anti-migratory effect of anti-angiogenic urokinase kringle domain.
    O E; Kim HK; Hong SH; Kim CK; Hong YK; Joe YA
    Oncol Rep; 2008 Sep; 20(3):631-6. PubMed ID: 18695916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyr61 and Fisp12 are both ECM-associated signaling molecules: activities, metabolism, and localization during development.
    Kireeva ML; Latinkić BV; Kolesnikova TV; Chen CC; Yang GP; Abler AS; Lau LF
    Exp Cell Res; 1997 May; 233(1):63-77. PubMed ID: 9184077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrin-dependent functions of the angiogenic inducer NOV (CCN3): implication in wound healing.
    Lin CG; Chen CC; Leu SJ; Grzeszkiewicz TM; Lau LF
    J Biol Chem; 2005 Mar; 280(9):8229-37. PubMed ID: 15611078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disintegrin interaction with alpha V beta 3 integrin on human umbilical vein endothelial cells: expression of ligand-induced binding site on beta 3 subunit.
    Juliano D; Wang Y; Marcinkiewicz C; Rosenthal LA; Stewart GJ; Niewiarowski S
    Exp Cell Res; 1996 May; 225(1):132-42. PubMed ID: 8635506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a novel integrin alphaMbeta2 binding site in CCN1 (CYR61), a matricellular protein expressed in healing wounds and atherosclerotic lesions.
    Schober JM; Lau LF; Ugarova TP; Lam SC
    J Biol Chem; 2003 Jul; 278(28):25808-15. PubMed ID: 12736251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased expression of CYR61, an extracellular matrix signaling protein, in human benign prostatic hyperplasia and its regulation by lysophosphatidic acid.
    Sakamoto S; Yokoyama M; Zhang X; Prakash K; Nagao K; Hatanaka T; Getzenberg RH; Kakehi Y
    Endocrinology; 2004 Jun; 145(6):2929-40. PubMed ID: 14988385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adhesion of endothelial cells to NOV is mediated by the integrins alphavbeta3 and alpha5beta1.
    Ellis PD; Metcalfe JC; Hyvönen M; Kemp PR
    J Vasc Res; 2003; 40(3):234-43. PubMed ID: 12902636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acurhagin-C, an ECD disintegrin, inhibits integrin alphavbeta3-mediated human endothelial cell functions by inducing apoptosis via caspase-3 activation.
    Wang WJ
    Br J Pharmacol; 2010 Jul; 160(6):1338-51. PubMed ID: 20590625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cysteine-rich 61 (CCN1) enhances chemotactic migration, transendothelial cell migration, and intravasation by concomitantly up-regulating chemokine receptor 1 and 2.
    Lin BR; Chang CC; Chen LR; Wu MH; Wang MY; Kuo IH; Chu CY; Chang KJ; Lee PH; Chen WJ; Kuo ML; Lin MT
    Mol Cancer Res; 2007 Nov; 5(11):1111-23. PubMed ID: 18025257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and function of CYR61, an angiogenic factor, in breast cancer cell lines and tumor biopsies.
    Tsai MS; Hornby AE; Lakins J; Lupu R
    Cancer Res; 2000 Oct; 60(20):5603-7. PubMed ID: 11059746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CYR61/CCN1 and WISP3/CCN6 are chemoattractive ligands for human multipotent mesenchymal stroma cells.
    Schütze N; Schenk R; Fiedler J; Mattes T; Jakob F; Brenner RE
    BMC Cell Biol; 2007 Oct; 8():45. PubMed ID: 17973995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61).
    Brigstock DR
    Angiogenesis; 2002; 5(3):153-65. PubMed ID: 12831056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyr61, a member of CCN family, is a tumor suppressor in non-small cell lung cancer.
    Tong X; Xie D; O'Kelly J; Miller CW; Muller-Tidow C; Koeffler HP
    J Biol Chem; 2001 Dec; 276(50):47709-14. PubMed ID: 11598125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eptifibatide and 7E3, but not tirofiban, inhibit alpha(v)beta(3) integrin-mediated binding of smooth muscle cells to thrombospondin and prothrombin.
    Lele M; Sajid M; Wajih N; Stouffer GA
    Circulation; 2001 Jul; 104(5):582-7. PubMed ID: 11479257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibronectin and vitronectin induce AP-1-mediated matrix metalloproteinase-9 expression through integrin α(5)β(1)/α(v)β(3)-dependent Akt, ERK and JNK signaling pathways in human umbilical vein endothelial cells.
    Jin YJ; Park I; Hong IK; Byun HJ; Choi J; Kim YM; Lee H
    Cell Signal; 2011 Jan; 23(1):125-34. PubMed ID: 20816750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast cancer. Cyr61 is overexpressed, estrogen-inducible, and associated with more advanced disease.
    Xie D; Miller CW; O'Kelly J; Nakachi K; Sakashita A; Said JW; Gornbein J; Koeffler HP
    J Biol Chem; 2001 Apr; 276(17):14187-94. PubMed ID: 11297518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.